Skip to content
healthcare.dev

RELAFEN DS

NDC 15370-170, NABUMETONE, tablet, from Carwin Pharmaceutical Associates, LLC.

Product NDC
15370-170
Status
Listed
Labeler
Carwin Pharmaceutical Associates, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203166
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/15370-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NABUMETONE1000 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
15370-170-1015370017010100 TABLET in 1 BOTTLE, PLASTIC (15370-170-10)
15370-170-301537001703030 TABLET in 1 BOTTLE, PLASTIC (15370-170-30)
15370-170-601537001706060 TABLET in 1 BOTTLE, PLASTIC (15370-170-60)
15370-170-99153700170991 BLISTER PACK in 1 CARTON (15370-170-99) / 2 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a9a0af85-6c43-4a2d-ba75-0be4ca64c931
  • NADAC price for package 15370017030

    GET /v1/drugs/nadac/15370017030
  • NADAC price for package 15370017060

    GET /v1/drugs/nadac/15370017060

Use it

Look up 15370-170 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/15370-170 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 15370-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.